VISCOLI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 61.018
AS - Asia 6.251
NA - Nord America 4.954
SA - Sud America 534
AF - Africa 102
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 72.868
Nazione #
IT - Italia 59.957
US - Stati Uniti d'America 4.612
SG - Singapore 2.647
CN - Cina 1.567
VN - Vietnam 940
FR - Francia 509
BD - Bangladesh 482
BR - Brasile 306
HK - Hong Kong 189
FI - Finlandia 142
CA - Canada 116
DE - Germania 94
AR - Argentina 86
GB - Regno Unito 74
JP - Giappone 68
MX - Messico 68
CH - Svizzera 55
IQ - Iraq 51
IN - India 47
CO - Colombia 39
JM - Giamaica 35
NL - Olanda 31
EC - Ecuador 29
ID - Indonesia 29
CR - Costa Rica 28
RU - Federazione Russa 28
PH - Filippine 26
PK - Pakistan 23
JO - Giordania 22
CL - Cile 20
ES - Italia 20
TT - Trinidad e Tobago 20
MA - Marocco 18
TH - Thailandia 18
VE - Venezuela 18
TR - Turchia 17
UA - Ucraina 16
ZA - Sudafrica 16
IE - Irlanda 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
MY - Malesia 14
NP - Nepal 14
PE - Perù 14
DZ - Algeria 13
PY - Paraguay 13
NI - Nicaragua 12
TN - Tunisia 12
HN - Honduras 11
ET - Etiopia 10
GT - Guatemala 10
KE - Kenya 9
KR - Corea 9
KZ - Kazakistan 8
PL - Polonia 8
RO - Romania 7
SE - Svezia 7
UY - Uruguay 7
AU - Australia 6
BG - Bulgaria 6
EG - Egitto 6
RS - Serbia 6
SV - El Salvador 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
PR - Porto Rico 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
AL - Albania 4
BB - Barbados 4
CZ - Repubblica Ceca 4
GP - Guadalupe 4
IR - Iran 4
BS - Bahamas 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
AT - Austria 2
BO - Bolivia 2
CG - Congo 2
CI - Costa d'Avorio 2
CU - Cuba 2
GE - Georgia 2
IL - Israele 2
KN - Saint Kitts e Nevis 2
MK - Macedonia 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
SI - Slovenia 2
AG - Antigua e Barbuda 1
Totale 72.835
Città #
Genova 38.338
Genoa 12.273
Rapallo 5.217
Vado Ligure 3.550
Singapore 1.256
San Jose 1.195
Ashburn 486
Lauterbourg 481
New York 316
Ho Chi Minh City 271
Beijing 260
Hanoi 247
Hong Kong 181
Council Bluffs 144
Helsinki 139
Los Angeles 139
Dallas 132
Santa Clara 132
Bordighera 114
Frankfurt am Main 81
Buffalo 55
Tokyo 55
Rome 53
Zurich 51
Milan 50
Mexico City 49
Orem 47
Houston 46
Chicago 42
San Francisco 41
Atlanta 40
Brooklyn 38
Da Nang 36
Haiphong 33
Naples 33
Denver 30
Phoenix 29
Tianjin 29
City of London 26
São Paulo 26
Kingston 24
Montreal 24
Las Vegas 23
Philadelphia 23
Amman 22
Toronto 21
Hải Dương 20
San José 20
Amsterdam 18
Baghdad 17
Biên Hòa 17
Bologna 16
Miami 15
Washington 15
Charlotte 14
Dublin 14
London 14
Shanghai 14
Des Moines 13
Dhaka 13
Shenzhen 13
The Bronx 13
Austin 12
Florence 12
Managua 12
Quito 12
Tashkent 12
Buenos Aires 11
Columbus 11
Guangzhou 11
Memphis 11
Queens 11
Rio de Janeiro 11
Seattle 11
Wilmington 11
Can Tho 10
Caracas 9
Guatemala City 9
Karachi 9
Lima 9
Newark 9
Paris 9
Santiago 9
Bogotá 8
Brasília 8
Cardiff 8
Catania 8
Chennai 8
Cleveland 8
Curitiba 8
Guayaquil 8
Jacksonville 8
Johannesburg 8
Kansas City 8
Minneapolis 8
San Juan 8
St Louis 8
Tampa 8
Thái Bình 8
Asunción 7
Totale 66.500
Nome #
Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium 709
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 251
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 249
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 245
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 234
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 234
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 234
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 230
Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1. 229
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 229
Bloodstream infections in patients living with HIV in the modern cART era 227
A tool for the evaluation of the cost effectiveness of AIDS therapies 226
Quality of Life Among Hiv Patients: Results from the Ianua Clinical Trial 225
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 225
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 224
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 224
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system 223
A Standard Interface for Data Reuse in Infectious Diseases 222
Trend of eGFR in an Italian cohort of mother-to-child HIV-infected patients exposed to tenofovir for at least 2 years. 221
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 212
La vaccinazione nel paziente con infezione da HIV: attuali raccomandazioni e strategie multidisciplinari per il raggiungimento dei soggetti suscettibili. L’esperienza della Liguria 212
Evaluation of insulin resistance in a cohort of HIV-infected youth. 211
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 211
Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery. 210
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 210
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 205
Implementing TB control in a rural, resource-limited setting: The stop-TB Italia project in Senegal 204
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. Study-Investigation on Antiretroviral Therapy) 202
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline 202
Use of colistin in adult patients: a cross-sectional study 202
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 200
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 200
Use of maraviroc in clinical practice: a multicenter observational study 198
Bacterial infections in hematopoietic stem cell transplantation recipients. 198
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 197
Quantitative ultrasound and bone density in vertically HIV-infected children. 195
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 194
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 194
Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. 193
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 193
Male patient with acute hepatitis E in Genoa, Italy: Figatelli (pork liver sausage) as probable source of the infection 191
Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis. 191
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 189
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 189
Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient 188
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 188
An Italian consensus for invasive candidiasis management (ITALIC). 187
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 187
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. 185
A case report of Absidia corymbifera soft-tissue infection with kidney involvement in a AIDS patient. 185
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 185
Prophylaxis and empirical therapy for infection in cancer patients 184
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 184
. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients 183
[Congenital hepatic fibrosis]. 182
Guillain-Barré syndrome following chickenpox: A case series 182
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 182
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 182
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 181
A case of secondary syphilis presenting as optic neuritis 179
Management of KPC-producing Klebsiella pneumoniae infections 179
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 179
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 178
Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course 178
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 178
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 178
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 177
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 176
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 176
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 176
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 175
Non-cultural methods for the diagnosis of invasive fungal disease 175
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 175
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 174
Invasive candidiasis in non-hematological patients. 174
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 174
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 174
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period 173
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 173
A European Organization for research and treatment of cancer international antimicrobial therapy group study of secondary infections in febrile, neutropenic patients with cancer 172
Different evidence of key amprenavir resistance mutations on the efficacy of darunavir 172
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 172
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 172
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 172
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 172
Galactomannan in piperacillin-tazobactam: how much and to what extent? 170
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to- child transmission of HIV in Europe 170
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations 169
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. 169
Vancomycin susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia isolates in an Italian hospital. 168
Invasive mycoses in children receiving hemopoietic SCT 168
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 168
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 167
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 167
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt 166
Genotypic determination of HIV tropism in a cohort of patients perinatally infected with HIV-1 and exposed to antiretroviral therapy. 166
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 165
HIV and accelerated atheroprogression: role of antiretroviral therapy. 165
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 165
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 165
Totale 19.690
Categoria #
all - tutte 229.642
article - articoli 212.202
book - libri 709
conference - conferenze 7.273
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.458
Totale 459.284


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.259 177 308 375 832 222 665 319 1.486 329 590 178 778
2022/20236.263 658 363 78 650 996 1.250 21 479 1.060 80 551 77
2023/20242.833 140 426 73 323 275 513 146 163 204 69 167 334
2024/20258.370 156 703 250 557 1.287 826 781 1.200 351 382 785 1.092
2025/202615.836 1.708 377 911 1.008 1.938 1.667 2.497 682 1.129 1.406 1.511 1.002
2026/20271.248 1.248 0 0 0 0 0 0 0 0 0 0 0
Totale 73.699